Clinical Drug Experience Knowledgebase

acetylsalicylic acid (aspirin) (7 trials)

amoxicillin (1 trial)

bismuth (1 trial)

clarithromycin (biaxin) (1 trial)

clostridium butyricum (1 trial)

cyclophosphamide (cytoxan) (4 trials)

dezocine (dalgan) (1 trial)

docetaxel (taxotere) (3 trials)

eltrombopag (promacta) (1 trial)

esomeprazole (nexium) (1 trial)

fluticasone (cutivate) (1 trial)

gimeracil (4 trials)

interferon alpha-2b (Intron-A) (1 trial)

lobaplatin (1 trial)

metformin (glucophage) (1 trial)

minocycline (minocin) (5 trials)

mosapride (1 trial)

oteracil (4 trials)

paclitaxel (taxol) (7 trials)

pioglitazone (actos) (1 trial)

polyethylene glycol (1 trial)

ramucirumab (cyramza) (1 trial)

tegafur (4 trials)

thrombopoietin (1 trial)

tranexamic acid (cyklokapron) (2 trials)

vancomycin (Vancocin) (1 trial)

venlafaxine (effexor) (1 trial)

zolmitriptan (zomig) (1 trial)

bevacizumab (avastin) (1 trial)

cisplatin (platinol) (3 trials)

doxorubicin (Doxil) (3 trials)

hydromorphone (diladid) (1 trial)

indomethacin (indocin) (1 trial)

nalbuphine (nubain) (1 trial)

pirarubicin (1 trial)

risperidone (risperdal) (1 trial)

sufentanil (1 trial)

anlotinib (6 trials)

capecitabine (xeloda) (4 trials)

carboplatin (paraplatin) (1 trial)

dexamethasone (2 trials)

entacapone (comtan) (1 trial)

epirubicin (ellence) (1 trial)

etoposide (vepesid) (1 trial)

fluorouracil (efudex) (2 trials)

hemay007 (1 trial)

ifosfamide (ifex) (1 trial)

insulin human (humulin) (1 trial)

interferon alpha-1 (1 trial)

lapatinib (tykerb) (1 trial)

leucovorin (2 trials)

lintuzumab (1 trial)

nimotuzumab (1 trial)

nitric oxide (inomax) (5 trials)

nitrogen (1 trial)

Olverembatinib (1 trial)

oxaliplatin (eloxatin) (8 trials)

polyvinyl pyrrolidone (1 trial)

rc48-adc (1 trial)

sintilimab (2 trials)

taurine (2 trials)

tislelizumab (1 trial)

toripalimab (LOQTORZ) (1 trial)

trastuzumab (herceptin) (1 trial)

venetoclax (venclexta) (1 trial)

wharton's jelly mesenchymal stem cells (2 trials)

xelox (1 trial)

zolpidem (ambien) (1 trial)

68ga labeled her2 affibody (1 trial)

68ga-sgc8 (1 trial)

bcma/cd19 dual-target car-t (1 trial)

berberine (1 trial)

bifidobacterium animalis (1 trial)

cardiac stem cells (1 trial)

cd147-car t cells (2 trials)

fludarabine (fludara) (1 trial)

mepolizumab (Nucala) (1 trial)

remifentanil (ultiva) (2 trials)

xyf19 car-t cell (1 trial)

ak104 (1 trial)

aminolevulinic acid (levulan) (1 trial)

atomoxetine (strattera) (1 trial)

beinaglutide (1 trial)

betamethasone (celestone) (1 trial)

bromocriptine (parlodel) (1 trial)

cabergoline (dostinex) (1 trial)

camrelizumab (1 trial)

ciprofol (1 trial)

clopidogrel (plavix) (4 trials)

dexmedetomidine (precedex) (1 trial)

dibotermin alpha (inductos) (1 trial)

etomidate (amidate) (1 trial)

flot regimen (1 trial)

folic acid (1 trial)

Fosaprepitant (1 trial)

gilbenclamide (1 trial)

halometasone (1 trial)

hlx10 (1 trial)

hyaluronic acid (1 trial)

hyaluronidase (bovine) (Wydase) (1 trial)

hydroxyethyl starch (voluven) (1 trial)

insulin glargine (toujeo) (1 trial)

inulin (1 trial)

isotretinoin (Accutane) (1 trial)

lactase (1 trial)

maltodextrin (2 trials)

melatonin (1 trial)

methylcobalamin (1 trial)

methylphenidate (ritalin) (1 trial)

minoxidil (loniten) (1 trial)

mometasone (elocon) (1 trial)

palonosetron (aloxi) (1 trial)

penpulimab (2 trials)

peony (1 trial)

petrolatum, white (Vaseline) (1 trial)

propofol (diprivan) (2 trials)

remimazolam (Byfavo) (1 trial)

rivaroxaban (xarelto) (2 trials)

rocuronium (zemuron) (1 trial)

sorafenib (nexavar) (1 trial)

stachyose (1 trial)

ticagrelor (brilinta) (3 trials)

umbilical cord mesenchymal stem cells (1 trial)

vitamin d3 (1 trial)

zinc (1 trial)